
Pratiti Bandopadhayay MD
Instructor, Pediatrics-Children's Hospital, Harvard Medical School
Join to view full profile
450 Brookline AveDana Farber Cancer Centre-Pediatric Neuro-OncBoston, MA 02215
Phone+1 857-600-5911
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 11 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pratiti Bandopadhayay, MD is a pediatric hematologist/oncologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Dana-Farber Cancer Institute and Boston Children's Hospital.
Education & Training
Monash University Faculty of MedicineClass of 2001
Certifications & Licensure
MA State Medical License 2013 - 2028
Publications & Presentations
PubMed
- 1 citationsO-mannosylation and protein maturation checkpoints represent therapeutic opportunities in BRAF fusion protein oncogenesis.Anna Borgenvik, Sean A Misek, Daniel Christen, Gloria Kyrila, Alexander Zhang
Cancer Discovery. 2026-09-09 - Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma.Chelsea Kotch, Sebastien Perreault, Phoebe Power, David J Adams, Kenneth Aldape
Neuro-Oncology. 2026-09-01 - O-mannosylation and furin processing are critical maturation events for the KIAA1549 protein implicated in pediatric pilocytic astrocytomas.Gloria Kyrila, Serpil Ahmed, Anna Borgenvik, Daniel Christen, Sean A Misek
The Journal of Biological Chemistry. 2026-08-07
Press Mentions
Dana-Farber Research Shows Promise for Targeted Therapies for Paediatric GliomasAugust 4th, 2025
Dana-Farber Research Shows Promise for Targeted Therapies for Pediatric GliomasJuly 31st, 2025
$75,000 Hannah’s Heroes Grant Given to Cancer ResearcherOctober 16th, 2017
Grant Support
- Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade gliomaDANA-FARBER CANCER INST2026–2031
- Targeting vulnerabilities of PPM1D-mutant gliomasDANA-FARBER CANCER INST2026–2028
- Targeting vulnerabilities of PPM1D-mutant gliomasDANA-FARBER CANCER INST2026–2028